Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $73.87, for a total transaction of $123,141.29. Following the transaction, the senior vice president now owns 20,710 shares in the company, valued […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) Director Heath Lukatch sold 5,000 shares of the company’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $71.50, for a total transaction of $357,500.00. Following the completion of the sale, the director now directly owns 5,625 shares in the […]
Victory Capital Management Inc. cut its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 6.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 430,949 shares of the company’s stock after selling 31,355 shares during the quarter. Victory Capital Management […]
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $67.35, but opened at $70.60. Vaxcyte shares last traded at $69.57, with a volume of 403,300 shares trading hands. Wall Street Analyst Weigh In Several brokerages have recently weighed in on […]
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as $66.48 and last traded at $66.41, with a volume of 180384 shares traded. The stock had previously closed at $64.31. Analyst Ratings Changes A number of analysts recently commented on […]